N/A
N=10
Ultra-high Frequency (500 KHz) Spinal Cord Stimulation for Treatment of Chronic Back Pain or Lower Limb Pain
Pain, Chronic · Pain, Back · Pain, Radiating
Bottom Line
View on ClinicalTrials.gov: NCT03543085 ↗Enrolled (actual)
10
Serious AEs
0.0%
Results posted
Oct 2021
Primary outcome: Primary: Change in Visual Analog Score From Baseline to Day 14 — -5.1 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- GiMer Medical MN 1000 External Stimulator (Device)
- Age
- Adult, Older Adult · 20+ yrs
- Sex
- All
- Sponsor
- GiMer Medical
- Primary completion
- Oct 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Visual Analog Score From Baseline to Day 14 |
-5.1 | — |
| PRIMARY Record Incidence of Adverse Events |
16 | — |
| SECONDARY The Brief Pain Inventory (BPI) |
— | — |
| SECONDARY Incidence of Stimulation-induced Paresthesia |
— | — |
| SECONDARY Pain Relief Medication Consumption |
— | — |
| SECONDARY Oswestry Low Back Pain Disability Questionnaire (ODI) |
— | — |
Summary
This study is a prospective, single-arm, open label, single center to confirm the effectiveness and safety of an ultra-high frequency (500 KHz) spinal cord stimulation in patients with chronic back pain or lower limb pain.
Eligibility Criteria
Inclusion Criteria
- Age ≧20 and ≦75
- Have a symptom of back or lower limb pain with a diagnosis related to spinal lesion, herniated disc, nerve injury, stenosis, failed back surgery syndrome (FBSS), complex regional pain syndrome (CRPS) or ischemic lower limb pain and have pain history of >6 months.
- Have an average pain score >5 by Visual Analogue Scale (VAS) on inclusion.
- Has failed to achieve adequate pain relief from prior pharmacologic treatments.
- In the judgement of the investigator, the subject is an appropriate candidate for the trial procedure.
- The subject is willing and able to comply with the procedure and requirements of this trial.
- The participant is able to understand and provide informed consent, and has signed their written informed consent in accordance with Institutional Review Board (IRB) requirements.
Exclusion Criteria
- Have evidence of a mental or psychological condition that affects pain perception and has difficulty/disability performing objective pain assessment, or have previously failed mental or psychological assessments administered by a psychiatrist that may be deemed to indicate the subject's lack of suitability for participation in this study.
- Subject has exhibited unstable pain condition within the past 30 days as interviewed by Investigator.
- Be on anticoagulant medication with International Normalized Ratio (INR) >1.5 or platelet count less than 100,000/μL, peripheral vascular diseases (PVDs), visceral pain or uncontrolled Diabetes mellitus (DM).
- Has had corticosteroid therapy at an intended site of stimulation within the past 30 days.
- Pain medication(s) dosages(s) are not stable for at least 30 days at investigator's discretion.
- Currently has an active implantable device including International Classification of Diseases (ICD), pacemaker, spinal cord stimulator or intrathecal drug pump or subject requires magnetic resonance imaging (MRIs) or diathermy.
- Have a current diagnosis of cancer with active symptoms.
- Have a known terminal illness with life expectancy less than one year.
- Have a systematic or local infection, which may increase study risk.
- Currently has an indwelling device that may pose an increased risk of infection.
- Be pregnant or breast feeding.
- Have a medical history of drug or alcohol addiction within the past 2 years.
- Participation in any investigational study in the last 30 days or current enrollment in any trial.
- Be currently involved in an injury claim law suit or medically related litigation, including workers compensation.
- Be a prisoner.
Data sourced from ClinicalTrials.gov (NCT03543085). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.